XML 46 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Revenue $ 1,157,917 $ 6,064 $ 1,460,958 $ 6,064
Cost of revenue 1,784,073 449,567 3,922,594 641,606
Gross loss (626,156) (443,503) (2,461,636) (635,542)
Operating expenses:        
Research and development 411,268 30,776 598,645 104,095
General and administrative 2,573,142 1,300,767 7,998,609 3,639,204
Total operating expenses 2,984,410 1,331,543 8,597,254 3,743,299
Loss from operations (3,610,566) (1,775,046) (11,058,890) (4,378,841)
Other (expense) income:        
Change in valuation of derivative liabilities 134,987 (3,311) 263,531 6,939
Interest expense (1,428,463) (1,552,006)
Interest income 2,199 61 16,583 411
True-up termination fee (1,344,648)
Settlement of promissory notes receivable (1,166,556) (1,166,556)
Liquidated damages (2,652,798) (2,667,798)
Total other (expense) income (5,110,631) (3,250) (6,450,894) 7,350
Loss before income taxes (8,721,197) (1,778,296) (17,509,784) (4,371,491)
Benefit for income taxes 91,633 91,633
Net loss (8,629,564) (1,778,296) (17,418,151) (4,371,491)
Deemed dividend on Series H convertible preferred stock (18,045,496) (18,045,496)
Net loss attributable to common shareholders $ (26,675,060) $ (1,778,296) $ (35,463,647) $ (4,371,491)
Basic and diluted net loss per common share $ (0.96) $ (0.11) $ (1.40) $ (0.33)
Weighted average number of common shares outstanding - basic and diluted 27,835,555 16,367,424 25,382,551 13,091,231